GH1 and metabolic syndrome: This study aimed to dissect how the alteration of ghrelin signaling pathway and GH/IGH-1 axis by CO is different from those induced by other MetS risk factors in order to understand the underlying mechanisms through which CO facilitates the development of cardiovascular diseases and metabolic disorders.